2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells

Autor: Stephan Nussberger, Alicja Kuban-Jankowska, Giosuè Lo Bosco, Giampaolo Barone, Stephan A. Eisler, Ugo Perricone, Magdalena Gorska-Ponikowska
Přispěvatelé: Gorska-Ponikowska, M., Kuban-Jankowska, A., Eisler, S., Perricone, U., Lo Bosco, G., Barone, G., Nussberger, S.
Rok vydání: 2017
Předmět:
0301 basic medicine
Cancer Research
SIRT3
Protein subunit
SDHA
Muscle Proteins
Antineoplastic Agents
Molecular Dynamics Simulation
Biochemistry
Electron Transport Complex IV
03 medical and health sciences
0302 clinical medicine
Genetic
Settore BIO/10 - Biochimica
Cell Line
Tumor

Sirtuin 3
Coactivator
Genetics
Humans
Molecular Biology
Osteosarcoma
Organelle Biogenesis
biology
Estradiol
Settore BIO/16 - Anatomia Umana
Chemistry
Electron Transport Complex II
Calcium-Binding Proteins
Membrane Proteins
Peroxisome
Mitochondrial biogenesi
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
Cell biology
2-Methoxyestradiol
Mitochondria
Succinate dehydrogenase
Molecular Docking Simulation
030104 developmental biology
Mitochondrial biogenesis
Settore CHIM/03 - Chimica Generale E Inorganica
030220 oncology & carcinogenesis
Sirtuin
Cancer cell
biology.protein
Research Article
Zdroj: Cancer genomicsproteomics. 15(1)
ISSN: 1790-6245
Popis: Background/aim Dysregulation of mitochondrial pathways is implicated in several diseases, including cancer. Notably, mitochondrial respiration and mitochondrial biogenesis are favored in some invasive cancer cells, such as osteosarcoma. Hence, the aim of the current work was to investigate the effects of 2-methoxyestradiol (2-ME), a potent anticancer agent, on the mitochondrial biogenesis of osteosarcoma cells. Materials and methods Highly metastatic osteosarcoma 143B cells were treated with 2-ME separately or in combination with L-lactate, or with the solvent (non-treated control cells). Protein levels of α-syntrophin and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) were determined by western blotting. Impact of 2-ME on mitochondrial mass, regulation of cytochrome c oxidase I (COXI) expression, and succinate dehydrogenase complex flavoprotein subunit A (SDHA) was determined by immunofluorescence analyses. Inhibition of sirtuin 3 (SIRT3) activity by 2-ME was investigated by fluorescence assay and also, using molecular docking and molecular dynamics simulations. Results L-lactate induced mitochondrial biogenesis pathway via up-regulation of COXI. 2-ME inhibited mitochondrial biogenesis via regulation of PGC-1α, COXI, and SIRT3 in a concentration-dependent manner as a consequence of nuclear recruitment of neuronal nitric oxide synthase and nitric oxide generation. It was also proved that 2-ME inhibited SIRT3 activity by binding to both the canonical and allosteric inhibitor binding sites. Moreover, regardless of the mitochondrial biogenesis pathway, 2-ME affected the expression of SDHA. Conclusion Herein, mitochondrial biogenesis pathway regulation and SDHA were presented as novel targets of 2-ME, and moreover, 2-ME was demonstrated as a potent inhibitor of SIRT3. L-lactate was confirmed to exert pro-carcinogenic effects on osteosarcoma cells via the induction of the mitochondrial biogenesis pathway. Thus, L-lactate level may be considered as a prognostic biomarker for osteosarcoma.
Databáze: OpenAIRE